{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:37Z","timestamp":1763036197532},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"32","license":[{"start":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T00:00:00Z","timestamp":1169424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T00:00:00Z","timestamp":1169424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2007,7,12]]},"DOI":"10.1038\/sj.onc.1210250","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T10:21:05Z","timestamp":1169461265000},"page":"4714-4719","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model"],"prefix":"10.1038","volume":"26","author":[{"given":"H","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,22]]},"reference":[{"key":"BF1210250_CR1","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","volume":"22","author":"ML Bajenaru","year":"2002","unstructured":"Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, Gutmann DH . (2002). Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol 22: 5100\u20135113.","journal-title":"Mol Cell Biol"},{"key":"BF1210250_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/356713a0","volume":"356","author":"TN Basu","year":"1992","unstructured":"Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J . (1992). Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713\u2013715.","journal-title":"Nature"},{"key":"BF1210250_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/347291a0","volume":"347","author":"AM Buchberg","year":"1990","unstructured":"Buchberg AM, Cleveland LS, Jenkins NA, Copeland NG . (1990). Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347: 291\u2013294.","journal-title":"Nature"},{"key":"BF1210250_CR4","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1073\/pnas.0510651103","volume":"103","author":"DN Chadee","year":"2006","unstructured":"Chadee DN, Xu D, Hung G, Andalibi A, Lim DJ, Luo Z et al. (2006). Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf\/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci USA 103: 4463\u20134468.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210250_CR5","first-page":"852","volume-title":"Soft Tissue Tumor","author":"FM Enzinger","year":"1988","unstructured":"Enzinger FM, Weiss SW . (1988). Soft Tissue Tumor, 2nd edn. The C.V. Mosby Company: Washington, pp 852\u2013863."},{"key":"BF1210250_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jmg.37.12.897","volume":"37","author":"DG Evans","year":"2000","unstructured":"Evans DG, Sainio M, Baser ME . (2000). Neurofibromatosis type 2. J Med Genet 37: 897\u2013904.","journal-title":"J Med Genet"},{"key":"BF1210250_CR7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14: 1617\u20131630.","journal-title":"Genes Dev"},{"key":"BF1210250_CR8","volume-title":"Manipulating the Mouse Embryo: A Laboratory Manual","author":"B Hogan","year":"1994","unstructured":"Hogan B, Constantin F, Lacy E . (1994). Manipulating the Mouse Embryo: A Laboratory Manual, 2nd edn. Cold Spring Harbor Press: New York."},{"key":"BF1210250_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","volume":"91","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA . (1999). Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg 91: 85\u201392.","journal-title":"J Neurosurg"},{"key":"BF1210250_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0925-4773(00)00308-7","volume":"94","author":"T Kunisada","year":"2000","unstructured":"Kunisada T, Yamazaki H, Hirobe T, Kamei S, Omoteno M, Tagaya H et al. (2000). Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech Dev 94: 67\u201378.","journal-title":"Mech Dev"},{"key":"BF1210250_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/dbio.1999.9327","volume":"212","author":"MM Lakkis","year":"1999","unstructured":"Lakkis MM, Golden JA, O'Shea S, Epstein JA . (1999). Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects. Dev Biol 212: 80\u201392.","journal-title":"Dev Biol"},{"key":"BF1210250_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0006-291X(03)00124-4","volume":"302","author":"JY Lim","year":"2003","unstructured":"Lim JY, Kim H, Kim YH, Kim SW, Huh PW, Lee KH et al. (2003). Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun 302: 238\u2013245.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1210250_CR13","doi-asserted-by":"publisher","first-page":"d887","DOI":"10.2741\/A331","volume":"3","author":"M Malumbres","year":"1998","unstructured":"Malumbres M, Pellicer A . (1998). RAS pathways to cell cycle control and cell transformation. Front Biosci 3: d887\u2013d912.","journal-title":"Front Biosci"},{"key":"BF1210250_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/jpet.105.091454","volume":"316","author":"RR Mattingly","year":"2006","unstructured":"Mattingly RR, Kraniak JM, Dilworth JT, Mathieu P, Bealmear B, Nowak JE et al. (2006). The mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines. J Pharmacol Exp Ther 316: 456\u2013465.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1210250_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","volume":"11","author":"AI McClatchey","year":"1997","unstructured":"McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T . (1997). The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev 11: 1253\u20131265.","journal-title":"Genes Dev"},{"key":"BF1210250_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1101\/gad.189601","volume":"15","author":"H Morrison","year":"2001","unstructured":"Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA et al. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15: 968\u2013980.","journal-title":"Genes Dev"},{"key":"BF1210250_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3","volume":"97","author":"K North","year":"2000","unstructured":"North K . (2000). Neurofibromatosis type 1. Am J Med Genet 97: 119\u2013127.","journal-title":"Am J Med Genet"},{"key":"BF1210250_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","volume":"15","author":"EE Patton","year":"2005","unstructured":"Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD et al. (2005). BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15: 249\u2013254.","journal-title":"Curr Biol"},{"key":"BF1210250_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1471-4914(01)01955-4","volume":"7","author":"N Reed","year":"2001","unstructured":"Reed N, Gutmann DH . (2001). Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med 7: 157\u2013162.","journal-title":"Trends Mol Med"},{"key":"BF1210250_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.bbrc.2005.04.043","volume":"331","author":"H Saito","year":"2005","unstructured":"Saito H, Tsumura H, Otake S, Nishida A, Furukawa T, Suzuki N . (2005). L7\/Pcp-2-specific expression of Cre recombinase using knock-in approach. Biochem Biophys Res Commun 331: 1216\u20131221.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1210250_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/jcs.103.1.131","volume":"103","author":"N Sato","year":"1992","unstructured":"Sato N, Funayama N, Nagafuchi A, Yoneyama S, Tsukita S, Tsukita S . (1992). A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament\/plasma membrane association sites. J Cell Sci 103: 131\u2013143.","journal-title":"J Cell Sci"},{"key":"BF1210250_CR22","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","volume":"269","author":"A Tikoo","year":"1994","unstructured":"Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H . (1994). The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. J Biol Chem 269: 23387\u201323390.","journal-title":"J Biol Chem"},{"key":"BF1210250_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/j.1460-2075.1992.tb05082.x","volume":"11","author":"K Tsukamoto","year":"1992","unstructured":"Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ . (1992). A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11: 519\u2013526.","journal-title":"EMBO J"},{"key":"BF1210250_CR24","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1038\/sj.onc.1209749","volume":"25","author":"H Tsumura","year":"2006","unstructured":"Tsumura H, Yoshida T, Saito H, Imanaka-Yoshida K, Suzuki N . (2006). Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Oncogene 25: 7673\u20137679.","journal-title":"Oncogene"},{"key":"BF1210250_CR25","doi-asserted-by":"publisher","first-page":"17164","DOI":"10.1074\/jbc.274.24.17164","volume":"274","author":"JK Voice","year":"1999","unstructured":"Voice JK, Klemke RL, Le A, Jackson JH . (1999). Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 274: 17164\u201317170.","journal-title":"J Biol Chem"},{"key":"BF1210250_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.1068452","volume":"296","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Ghosh P, Chammay P, Bums DK, Parada LF . (2002). Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920\u2013922.","journal-title":"Science"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210250","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T09:38:25Z","timestamp":1647941905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,22]]},"references-count":26,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2007,7,12]]}},"alternative-id":["BF1210250"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210250","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,22]]},"assertion":[{"value":"18 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}